Lena is a litigation lawyer specialising in the life sciences sector. She advises companies on out-of-court dispute resolution and represents them before state courts or arbitration tribunals. She has particular experience in advising and representing pharmaceutical and medtech companies.
Lena specialises in disputes between companies in connection with purchasing, development, production and distribution. She is also an expert in product liability and product safety issues and has many years of experience in representing companies in product liability proceedings, including the defence of class actions.
Lexology In-Depth: Product Regulation and Liability, European Union Chapter
Niehoff/Moelle, MPR 2024, 35 ff., Zur Frage eines Produktfehlers bei einem Bruch einer Hüftendoprothese, Anm. zu BGH, Urteil from 1 August 2023, VI ZR 82/22
German Chapter in Chambers Global Practical Guide Product Liability & Safety 2023, together with Dr. Henning Moelle, Dr. Philipp Behrendt and Donata von Enzberg
Marke verpflichtet – zur Produkthaftung der Markeninhaberin, ECJ judgment of July 7, 2022 – C-264/21, in: Deutscher AnwaltSpiegel, Issue 24, 2022
One to Watch: Litigation
Representing AstraZeneca in all product liability proceedings relating to its COVID-19 vaccine in Germany.
New product liability risks for AI products
The new Product Liability Directive aims to modernise the product liability rules and remove obstacles for consumers. What should life sciences companies using AI in products know about the new product liability rules.
5 / 10 观点
Product liability and safety horizon scanning – what to look out for in 2025
作者
作者
作者
作者 Ed Chapman 以及 Jack Coventry
作者 Kathleen Munstermann-Senff, LL.M. (Medical Law) 以及 Dr. Daniel Tietjen